[HTML][HTML] CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation

T Arnould, S Vankoningsloo, P Renard… - The EMBO …, 2002 - embopress.org
T Arnould, S Vankoningsloo, P Renard, A Houbion, N Ninane, C Demazy, J Remacle…
The EMBO journal, 2002embopress.org
We characterized a new signaling pathway leading to the activation of cAMP‐responsive
element‐binding protein (CREB) in several cell lines affected by mitochondrial dysfunction.
In vitro kinase assays, inhibitors of several kinase pathways and overexpression of a
dominant‐negative mutant for calcium/calmodulin kinase IV (CaMKIV), which blocks the
activation of CREB, showed that CaMKIV is activated by a mitochondrial activity impairment.
A high calcium concentration leading to the disruption of the protein interaction with protein …
Abstract
We characterized a new signaling pathway leading to the activation of cAMP‐responsive element‐binding protein (CREB) in several cell lines affected by mitochondrial dysfunction. In vitro kinase assays, inhibitors of several kinase pathways and overexpression of a dominant‐negative mutant for calcium/calmodulin kinase IV (CaMKIV), which blocks the activation of CREB, showed that CaMKIV is activated by a mitochondrial activity impairment. A high calcium concentration leading to the disruption of the protein interaction with protein phosphatase 2A explains CaMKIV activation in these conditions. Transcrip tionally active phosphorylated CREB was also found in a ρ0 143B human osteosarcoma cell line and in a MERRF cybrid cell line mutated for tRNA Lys (A8344G). We also showed that phosphorylated CREB is involved in the proliferation defect induced by a mitochondrial dysfunction. Indeed, cell proliferation inhibition can be prevented by CaMKIV inhibition and CREB dominant‐negative mutants. Finally, our data suggest that phosphorylated CREB recruits p53 tumor suppressor protein, modifies its transcriptional activity and increases the expression of p21 Waf1/Cip1, a p53‐regulated cyclin‐dependent kinase inhibitor.
embopress.org